Board of Directors: James H. Sabry, M.D., Ph.D.
James H. Sabry, M.D., Ph.D.
Board Member
James joined the HopeLab board of directors in May 2006. He is Vice President of Partnering at Genentech, one of the world’s leading biotech companies.
Dr. Sabry is former president and chief executive officer of Arete Therapeutics, Inc., a privately-held pharmaceutical company discovering and developing first-in-class small-molecule drugs. James is also former CEO and chairman of the board of directors of Cytokinetics, a company he co-founded in August 1997. Prior to Cytokinetics, James held faculty positions at the University of California, San Francisco, and Harvard Medical School. He has been a recipient of the Damon Runyon Walter Winchell Fellowship in Cancer Biology and a postdoctoral fellowship at Stanford University recipient and is the author of numerous scientific papers.
James has held professional positions with the World Economic Forum in Geneva, the John F. Kennedy School of Government at Harvard, the Brigham and Women’s Hospital at Harvard, and the Mayfield Fund. He is a member of the Council of the American Society of Cell Biology, and is also a member of the American Society of Clinical Oncology.
James received an M.D. from Queen’s University, in Kingston, Canada, and a Ph.D. in cell biology from the University of California, San Francisco.
